Timely detection of mild cognitive impairment in Italy: An expert opinion

Angelo Bianchetti, Nicola Ferrara, Alessandro Padovani, Elio Scarpini, Marco Trabucchi, Stefania Maggi

Research output: Contribution to journalReview article

Abstract

Mild cognitive impairment (MCI) generally evolves in a gradually progressive decline in memory and non-memory cognitive domains that may eventually decay to dementia. This process might be preventable by improving early detection of the MCI syndrome followed by proper and timely interventions. The aim of this work was providing helpful indications for a standardized early diagnosis of MCI, mainly focusing on the Italian elderly population.We reviewed here MCI epidemiology and classification, as well as the most recent advancements in early detection of the patient with MCI in the Italian scenario. Specialist centers in connection with general practitioners (GPs) have been established across the country and designated as Centers for Cognitive Disorders and Dementia (CDCD). CDCDs are dedicated to the diagnosis and management of patients for all forms of dementia across all the complex staging spectrum. New tools were made available by the advancements of imaging techniques and of the research on biomarkers, leading to novel approaches based on the combination of imaging and biomarker detection, to improve accuracy and effectiveness in the early diagnosis of MCI. Moreover, patient genotyping, alone or in combination with other techniques, was also revealed as a promising method in evaluating and preventing MCI progression. We recommend the introduction of all these novel tools in the diagnostic practice of the specialist centers and that further efforts and resources are spent into the research of the most effective techniques and biomarkers to be introduced as first-level tests into the practice of early diagnosis of MCI.

Original languageEnglish
Pages (from-to)1401-1414
Number of pages14
JournalJournal of Alzheimer's Disease
Volume68
Issue number4
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Expert Testimony
Italy
Dementia
Early Diagnosis
Biomarkers
Cognitive Dysfunction
General Practitioners
Epidemiology
Research Design
Research
Population

Keywords

  • Biomarkers
  • Early diagnosis
  • Genotyping
  • Imaging
  • Mild cognitive impairment
  • Neuropsychological assessment

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Timely detection of mild cognitive impairment in Italy : An expert opinion. / Bianchetti, Angelo; Ferrara, Nicola; Padovani, Alessandro; Scarpini, Elio; Trabucchi, Marco; Maggi, Stefania.

In: Journal of Alzheimer's Disease, Vol. 68, No. 4, 01.01.2019, p. 1401-1414.

Research output: Contribution to journalReview article

Bianchetti, A, Ferrara, N, Padovani, A, Scarpini, E, Trabucchi, M & Maggi, S 2019, 'Timely detection of mild cognitive impairment in Italy: An expert opinion', Journal of Alzheimer's Disease, vol. 68, no. 4, pp. 1401-1414. https://doi.org/10.3233/JAD-181253
Bianchetti, Angelo ; Ferrara, Nicola ; Padovani, Alessandro ; Scarpini, Elio ; Trabucchi, Marco ; Maggi, Stefania. / Timely detection of mild cognitive impairment in Italy : An expert opinion. In: Journal of Alzheimer's Disease. 2019 ; Vol. 68, No. 4. pp. 1401-1414.
@article{aa865562a93b4772a8458b1406a82d05,
title = "Timely detection of mild cognitive impairment in Italy: An expert opinion",
abstract = "Mild cognitive impairment (MCI) generally evolves in a gradually progressive decline in memory and non-memory cognitive domains that may eventually decay to dementia. This process might be preventable by improving early detection of the MCI syndrome followed by proper and timely interventions. The aim of this work was providing helpful indications for a standardized early diagnosis of MCI, mainly focusing on the Italian elderly population.We reviewed here MCI epidemiology and classification, as well as the most recent advancements in early detection of the patient with MCI in the Italian scenario. Specialist centers in connection with general practitioners (GPs) have been established across the country and designated as Centers for Cognitive Disorders and Dementia (CDCD). CDCDs are dedicated to the diagnosis and management of patients for all forms of dementia across all the complex staging spectrum. New tools were made available by the advancements of imaging techniques and of the research on biomarkers, leading to novel approaches based on the combination of imaging and biomarker detection, to improve accuracy and effectiveness in the early diagnosis of MCI. Moreover, patient genotyping, alone or in combination with other techniques, was also revealed as a promising method in evaluating and preventing MCI progression. We recommend the introduction of all these novel tools in the diagnostic practice of the specialist centers and that further efforts and resources are spent into the research of the most effective techniques and biomarkers to be introduced as first-level tests into the practice of early diagnosis of MCI.",
keywords = "Biomarkers, Early diagnosis, Genotyping, Imaging, Mild cognitive impairment, Neuropsychological assessment",
author = "Angelo Bianchetti and Nicola Ferrara and Alessandro Padovani and Elio Scarpini and Marco Trabucchi and Stefania Maggi",
year = "2019",
month = "1",
day = "1",
doi = "10.3233/JAD-181253",
language = "English",
volume = "68",
pages = "1401--1414",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - Timely detection of mild cognitive impairment in Italy

T2 - An expert opinion

AU - Bianchetti, Angelo

AU - Ferrara, Nicola

AU - Padovani, Alessandro

AU - Scarpini, Elio

AU - Trabucchi, Marco

AU - Maggi, Stefania

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Mild cognitive impairment (MCI) generally evolves in a gradually progressive decline in memory and non-memory cognitive domains that may eventually decay to dementia. This process might be preventable by improving early detection of the MCI syndrome followed by proper and timely interventions. The aim of this work was providing helpful indications for a standardized early diagnosis of MCI, mainly focusing on the Italian elderly population.We reviewed here MCI epidemiology and classification, as well as the most recent advancements in early detection of the patient with MCI in the Italian scenario. Specialist centers in connection with general practitioners (GPs) have been established across the country and designated as Centers for Cognitive Disorders and Dementia (CDCD). CDCDs are dedicated to the diagnosis and management of patients for all forms of dementia across all the complex staging spectrum. New tools were made available by the advancements of imaging techniques and of the research on biomarkers, leading to novel approaches based on the combination of imaging and biomarker detection, to improve accuracy and effectiveness in the early diagnosis of MCI. Moreover, patient genotyping, alone or in combination with other techniques, was also revealed as a promising method in evaluating and preventing MCI progression. We recommend the introduction of all these novel tools in the diagnostic practice of the specialist centers and that further efforts and resources are spent into the research of the most effective techniques and biomarkers to be introduced as first-level tests into the practice of early diagnosis of MCI.

AB - Mild cognitive impairment (MCI) generally evolves in a gradually progressive decline in memory and non-memory cognitive domains that may eventually decay to dementia. This process might be preventable by improving early detection of the MCI syndrome followed by proper and timely interventions. The aim of this work was providing helpful indications for a standardized early diagnosis of MCI, mainly focusing on the Italian elderly population.We reviewed here MCI epidemiology and classification, as well as the most recent advancements in early detection of the patient with MCI in the Italian scenario. Specialist centers in connection with general practitioners (GPs) have been established across the country and designated as Centers for Cognitive Disorders and Dementia (CDCD). CDCDs are dedicated to the diagnosis and management of patients for all forms of dementia across all the complex staging spectrum. New tools were made available by the advancements of imaging techniques and of the research on biomarkers, leading to novel approaches based on the combination of imaging and biomarker detection, to improve accuracy and effectiveness in the early diagnosis of MCI. Moreover, patient genotyping, alone or in combination with other techniques, was also revealed as a promising method in evaluating and preventing MCI progression. We recommend the introduction of all these novel tools in the diagnostic practice of the specialist centers and that further efforts and resources are spent into the research of the most effective techniques and biomarkers to be introduced as first-level tests into the practice of early diagnosis of MCI.

KW - Biomarkers

KW - Early diagnosis

KW - Genotyping

KW - Imaging

KW - Mild cognitive impairment

KW - Neuropsychological assessment

UR - http://www.scopus.com/inward/record.url?scp=85064869871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064869871&partnerID=8YFLogxK

U2 - 10.3233/JAD-181253

DO - 10.3233/JAD-181253

M3 - Review article

C2 - 30958367

AN - SCOPUS:85064869871

VL - 68

SP - 1401

EP - 1414

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -